Abstract:Transcription activator-like effectors (TALEs), first identified in Xanthomonas bacteria, are naturally occurring or artificially designed proteins that modulate gene transcription. These proteins recognize and bind DNA sequences based on a variable numbers of tandem repeats. Each repeat is comprised of a set of ∼ 34 conserved amino acids; within this conserved domain, there are usually two amino acids that distinguish one TALE from another. Interestingly, TALEs have revealed a simple cipher for the one-to-one recognition of proteins for DNA bases. Synthetic TALEs have been used to successfully target genes in a variety of species, including humans. Depending on the type of functional domain that is fused to the TALE of interest, these proteins can have diverse biological effects. For example, after binding DNA, TALEs fused to transcriptional activation domains can function as robust transcription factors (TALE-TFs), while fused to restriction endonucleases (TALENs) can cut DNA. Targeted genome editing, in theory, is capable of modifying any endogenous gene sequence of interest; this can be performed in cells or organisms, and may be applied to clinical gene-based therapies in the future. With current technologies, highly accurate, specific, and reliable gene editing cannot be achieved. Thus, recognition and binding mechanisms governing TALE biology are currently hot research areas. In this review, we summarize the major advances in TALE technology over the past several years with a focus on the interaction between TALEs and DNA, TALE design and construction, potential applications for this technology, and unique characteristics that make TALEs superior to zinc finger endonucleases.

Genome Targeting Modification Technology Based on TALE Nuclease Engineering

[TALE Nuclease Engineering and Targeted Genome Modification].

Molecular “Scissors” ——TALENs Mediated Site-specific Gene Modification Technology

Various applications of TALEN- and CRISPR/Cas9-mediated homologous recombination to modify the Drosophila genome.

[Applications of ZFN, TALEN and CRISPR/Cas9 Techniques in Disease Modeling and Gene Therapy].

Transcription Activator‐like Effector Nucleases (talens): A Highly Efficient and Versatile Tool for Genome Editing

Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.

TALE: a tale of genome editing.

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

[Advances in Genetic Modification Technologies].

De Novo-Engineered Transcription Activator-Like Effector (TALE) Hybrid Nuclease with Novel DNA Binding Specificity Creates Double-Strand Breaks.

New Method for Studying Plant Gene Function

A TALE nuclease architecture for efficient genome editing

Progress in zinc finger nuclease engineering for targeted genome modification]

Talen or Cas9-Rapid, Efficient and Specific Choices for Genome Modifications

ZFNs, TALENs and CRISPR-Cas Targeted Genome Editing Technologies and Their Applications in Plants

Genome-Editing Technologies: Principles and Applications.

Transcription activator‐like effector nucleases (TALENs): An efficient tool for plant genome editing

Site-specific Gene Targeting Using Transcription Activator-Like Effector (Tale)-Based Nuclease in Brassica Oleracea.

Application of Zinc Finger Nucleases in Genome Targeting Modification

Modularly Assembled Designer TAL Effector Nucleases for Targeted Gene Knockout and Gene Replacement in Eukaryotes.